Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A-375 | Vemurafenib | Saracatinib | 1.000 | 0.000 | uM | 72 | hr | 2 | 3900 | 189 | 0.1943 | 0.1915 | 0.0485 | 0.0418 |
A-375 | Vemurafenib | Saracatinib | 1.000 | 0.316 | uM | 72 | hr | 2 | 2557 | 190 | 0.1239 | 0.1190 | 0.0743 | 0.0733 |
A-375 | Vemurafenib | Saracatinib | 1.000 | 0.316 | uM | 72 | hr | 3 | 2475 | 183 | 0.1200 | 0.1190 | 0.0739 | 0.0733 |
A-375 | Vemurafenib | Saracatinib | 1.000 | 1.000 | uM | 72 | hr | 2 | 1536 | 170 | 0.0715 | 0.0717 | 0.1107 | 0.0989 |
A-375 | Vemurafenib | Saracatinib | 1.000 | 1.000 | uM | 72 | hr | 3 | 1386 | 125 | 0.0660 | 0.0717 | 0.0902 | 0.0989 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 0.000 | uM | 72 | hr | 1 | 20360 | 1046 | 1.0111 | 1.0000 | 0.0514 | 0.0527 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 0.000 | uM | 72 | hr | 2 | 20251 | 1109 | 1.0021 | 1.0000 | 0.0548 | 0.0527 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 0.316 | uM | 72 | hr | 1 | 16059 | 813 | 0.7981 | 0.7489 | 0.0506 | 0.0459 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 0.316 | uM | 72 | hr | 2 | 14559 | 660 | 0.7276 | 0.7489 | 0.0453 | 0.0459 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 1.000 | uM | 72 | hr | 2 | 9020 | 322 | 0.4553 | 0.4801 | 0.0357 | 0.0412 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 1.000 | uM | 72 | hr | 3 | 9724 | 364 | 0.4900 | 0.4801 | 0.0374 | 0.0412 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 3.160 | uM | 72 | hr | 2 | 6541 | 255 | 0.3291 | 0.3648 | 0.0390 | 0.0413 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 3.160 | uM | 72 | hr | 3 | 6145 | 245 | 0.3089 | 0.3648 | 0.0399 | 0.0413 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 0.316 | uM | 72 | hr | 1 | 5747 | 125 | 0.2943 | 0.3050 | 0.0218 | 0.0212 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 0.316 | uM | 72 | hr | 2 | 6343 | 121 | 0.3257 | 0.3050 | 0.0191 | 0.0212 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 1.000 | uM | 72 | hr | 1 | 4016 | 78 | 0.2061 | 0.2010 | 0.0194 | 0.0218 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 1.000 | uM | 72 | hr | 2 | 4327 | 93 | 0.2216 | 0.2010 | 0.0215 | 0.0218 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 3.160 | uM | 72 | hr | 2 | 3199 | 50 | 0.1648 | 0.1687 | 0.0156 | 0.0176 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 3.160 | uM | 72 | hr | 3 | 2686 | 53 | 0.1378 | 0.1687 | 0.0197 | 0.0176 |
A-375 | Vemurafenib | Saracatinib | 0.316 | 0.000 | uM | 72 | hr | 2 | 4759 | 106 | 0.2436 | 0.2452 | 0.0223 | 0.0214 |
A-375 | Vemurafenib | Saracatinib | 0.316 | 0.000 | uM | 72 | hr | 3 | 4787 | 110 | 0.2448 | 0.2452 | 0.0230 | 0.0214 |
A-375 | Vemurafenib | Saracatinib | 0.316 | 1.000 | uM | 72 | hr | 2 | 2270 | 89 | 0.1142 | 0.1035 | 0.0392 | 0.0423 |
A-375 | Vemurafenib | Saracatinib | 0.316 | 1.000 | uM | 72 | hr | 3 | 1827 | 89 | 0.0910 | 0.1035 | 0.0487 | 0.0423 |
A-375 | Vemurafenib | Saracatinib | 3.160 | 0.000 | uM | 72 | hr | 2 | 3197 | 255 | 0.1540 | 0.1538 | 0.0798 | 0.0753 |
A-375 | Vemurafenib | Saracatinib | 3.160 | 0.000 | uM | 72 | hr | 1 | 3381 | 232 | 0.1648 | 0.1538 | 0.0686 | 0.0753 |